- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:10 | Legales MDMA: Bioxyne geht nächsten Schritt | Small- & Micro Cap Investment | |||
| 06:10 | Surrozen: Direktorin Shao-Lee Lin tritt mit sofortiger Wirkung zurück | 3 | Investing.com Deutsch | ||
| 00:06 | Helix BioPharma Corp (2): Helix BioPharma holders OK all business items at AGM | 1 | Stockwatch | ||
| Fr | If You Invested $100 In Amneal Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today | 2 | Benzinga.com | ||
| Fr | Origin Agritech reports FY results | 2 | Seeking Alpha | ||
| Fr | Tenaya Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Origin Agritech LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| Fr | CAPRICOR THERAPEUTICS, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| Fr | Spero Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | Olema Pharmaceuticals: Aktie fällt nach angekündigtem CFO-Abgang | 2 | Investing.com Deutsch | ||
| Fr | IO Biotech, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | BioAtla, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| Fr | Helix BioPharma Corp. Announces Voting Results from its Annual General and Special Meeting | 1 | TheNewswire | ||
| Fr | Galmed Pharmaceuticals: Nasdaq-Notierung nach Kursverfall gefährdet | 1 | Investing.com Deutsch | ||
| Fr | ALUMIS INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| Fr | Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice | 2 | Seeking Alpha | ||
| Fr | Galmed Pharmaceuticals receives Nasdaq minimum bid price notice | 1 | Investing.com | ||
| Fr | ME Therapeutics Holdings Inc: ME Therapeutics talks pipeline and in vivo CAR plans | 1 | Stockwatch | ||
| Fr | Olema Oncology: Finanzvorstand Shane Kovacs verlässt das Unternehmen nach sechsjähriger Amtszeit | 1 | Investing.com Deutsch | ||
| Fr | Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 20 | 22 | +0,16 % | Regeneron Pharmaceuticals Inc Bottom Line Retreats In Q4 | WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc (REGN) announced a profit for fourth quarter that Drops, from the same period last yearThe company's earnings totaled $844.6 million, or... ► Artikel lesen | ||
| EVOTEC | 11 | 44 | -0,80 % | Puma-Übernahme wird konkreter! Als nächstes Evotec und Silver Viper Aktien kaufen? | Schon länger gibt es Übernahmespekulationen rund um Puma. Jetzt hat sich Anta 29 % am deutschen Sportartikelkonzern gesichert. Dafür zahlen die Chinesen 35 EUR je Aktie. An der Börse hält sich die Euphorie... ► Artikel lesen | ||
| BIONTECH | 10 | 13 | -0,21 % | Pharma- und Biotech-Aktien 2026: Bayer und BioNTech geben Gas, Bioxyne vor Durchbruch? | |||
| STRYKER | 9 | 19 | -0,13 % | Ihre wichtigsten Termine: Apple, Visa, Stryker, Blackstone, Mastercard & Samsung mit neuen Zahlen-Updates | © Foto: Andrej Sokolow/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 02:00... ► Artikel lesen | ||
| MODERNA | 9 | 16 | -1,17 % | Moderna, Inc.: Dr. David Berman to Join Moderna as Chief Development Officer | CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company's Chief Development Officer... ► Artikel lesen | ||
| AMGEN | 8 | 27 | -0,10 % | Amgen, Kyowa Kirin End Collaboration On Atopic Dermatitis Drug Rocatinlimab | THOUSAND OAKS (dpa-AFX) - Kyowa Kirin Co., Ltd. (KYKOY) said on Friday it has ended its development and commercialization partnership with Amgen for rocatinlimab, with the Japanese drugmaker... ► Artikel lesen | ||
| ALX ONCOLOGY | 7 | 2 | +11,54 % | ALX Oncology announces pricing of underwritten offering; shares up nearly 15% | |||
| ILLUMINA | 7 | - | -0,08 % | Illumina, Inc.: Illumina completes acquisition of SomaLogic from Standard BioTools Inc. | Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina's... ► Artikel lesen | ||
| LEXICON PHARMACEUTICALS | 6 | 4 | +1,90 % | Lexicon Pharmaceuticals, Inc.: Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement | THE WOODLANDS, Texas, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) ("Lexicon") today announced the pricing of its previously announced underwritten public offering... ► Artikel lesen | ||
| QUINCE THERAPEUTICS | 5 | 1 | -36,85 % | Quince Therapeutics on the brink as steroid-in-blood-cell fails in rare genetic disease |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 0,770 | 3 | +290 % | 1 | 1 | - | |||
| NANOREPRO AG | 1,530 | 4,50 | +194 % | 1 | - | - | |||
| SARTORIUS STEDIM BIOTECH SA | 188,20 | 248,20 | +32 % | 6 | 1 | - | |||
| EVOTEC SE | 6,218 | 8 | +29 % | 3 | 1 | - | |||
| BIONTECH SE ADR | 95,80 | 120,93 | +26 % | 7 | 1 | - | |||
| ARGENX SE | 710,20 | 823,50 | +16 % | 6 | 3 | - | |||
| QIAGEN NV | 44,620 | 46 | +3 % | 10 | 3 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.